17-44372364-T-TCACTC
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PP4_ModeratePM4PM2_SupportingPM3_Supporting
This summary comes from the ClinGen Evidence Repository: The stop loss NM_000419.5(ITGA2B):c.3115_3119dup variant causes Ter1040Trp and extension of the protein by 92 amino acids (PM4). It has been observed in the homozygous state in one patient with a phenotype highly specific to GT, including mucocutaneous bleeding, impaired aggregation with all agonists except ristocetin, and <5% surface expression of αIIbβ3 measured by flow cytometry (PMID:19691478; PP4_moderate, PM3_supporting). This variant is absent from gnomADv2.1.1 (PM2_Supporting). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: PM2_supporting, PM4, PP4_moderate, PM3_supporting (PD VCEP specifications version 2.1). LINK:https://erepo.genome.network/evrepo/ui/classification/CA915940262/MONDO:0010119/011
Frequency
Consequence
NM_000419.5 frameshift, stop_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ITGA2B | NM_000419.5 | c.3119_3120insGAGTG | p.Ter1040TrpfsTer? | frameshift_variant, stop_lost | 30/30 | ENST00000262407.6 | |
ITGA2B | XM_011524749.2 | c.3170_3171insGAGTG | p.Ter1057TrpfsTer? | frameshift_variant, stop_lost | 29/29 | ||
ITGA2B | XM_011524750.2 | c.3155_3156insGAGTG | p.Ter1052TrpfsTer? | frameshift_variant, stop_lost | 29/29 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ITGA2B | ENST00000262407.6 | c.3119_3120insGAGTG | p.Ter1040TrpfsTer? | frameshift_variant, stop_lost | 30/30 | 1 | NM_000419.5 | P1 | |
ITGA2B | ENST00000587295.5 | c.312_313insGAGTG | p.Ter105TrpfsTer? | frameshift_variant, stop_lost | 3/3 | 3 | |||
ITGA2B | ENST00000648408.1 | c.2433_2434insGAGTG | p.Ter812TrpfsTer? | frameshift_variant, stop_lost | 25/25 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Glanzmann thrombasthenia Pathogenic:1
Likely pathogenic, reviewed by expert panel | curation | ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen | Aug 15, 2023 | The stop loss NM_000419.5(ITGA2B):c.3115_3119dup variant causes Ter1040Trp and extension of the protein by 92 amino acids (PM4). It has been observed in the homozygous state in one patient with a phenotype highly specific to GT, including mucocutaneous bleeding, impaired aggregation with all agonists except ristocetin, and <5% surface expression of αIIbβ3 measured by flow cytometry (PMID: 19691478; PP4_moderate, PM3_supporting). This variant is absent from gnomADv2.1.1 (PM2_Supporting). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: PM2_supporting, PM4, PP4_moderate, PM3_supporting (PD VCEP specifications version 2.1). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at